Üremik Kemik Hastalığı ve Kanıta Dayalı Tedavi Bakım Uygulamaları
Özet
Üremik kemik hastalığı, kronik böbrek hastalığı ile ilişkili kemik morfolojisindeki bozuklukları tanımlamak için kullanılmaktadır. Kronik böbrek yetmezliğinde fosfor, kalsiyum ve D vitamini dengesinin bozulması ve parathormon düzeyinin artışı sonucu, kemik yapımı ve yıkımı arasında dengesizlikler ortaya çıkar. Hastalarda kemiklerde zayıflama, kemik ağrısı, kas-tendon yırtılması, kaşıntı ve yüksek kırık riski bulguları görülür. Üremik kemik hastalığının yönetiminde diyaliz tedavisi, fosfat, kalsiyum, D vitamini ve PTH'nin sıkı kontrolü önerilmektedir. Nefroloji Hemşirelerinin motivasyonel görüşme, eğitim ve danışmanlık girişimleri, üremik kemik hastalığının yönetiminde hastaların karmaşık tedavi ve diyet planlarına uyumunu artırdığı, öz-yönetim becerilerini geliştirdiği, laboratuar bulgularını ve yaşam tarzı değişikliklerini iyileştirdiği gösterilmiştir.
Referanslar
. Shah A, Aeddula NR. Renal Osteodystrophy. In: In: StatPearls [Internet]. Bethesda, MD 20894 USA: Treasure Island (FL): StatPearls Publishing; 2024. p. 1–18. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560742/
Hsu CY, Chen LR, Chen KH. Osteoporosis in patients with chronic kidney diseases: A systemic review. Int J Mol Sci. 2020;21(18):1–24.
Eknoyan G, Moe SM. Renal osteodystrophy: A historical review of its origins and conceptual evolution. Bone Reports [Internet]. 2022;17(October):101641. Available from: https://doi.org/10.1016/j.bonr.2022.101641
Delanaye P, Souberbielle JC, Lafage-Proust MH, Jean G, Cavalier E. Can we use circulating biomarkers to monitor bone turnover in CKD haemodialysis patients? Hypotheses and facts. Nephrol Dial Transplant. 2014;29(5):997–1004.
Viegas C, Araújo N, Marreiros C, Simes D. The interplay between mineral metabolism, vascular calcification and inflammation in Chronic Kidney Disease (CKD): Challenging old concepts with new facts. Aging (Albany NY). 2019;11(12):4274–99.
Moe S, Drüeke T, Cunningham J, Goodman W, Martin K, Olgaard K, et al. Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2006;69(11):1945–53.
Zhou L, Fu P. The interpretation of KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Chinese J Evidence-Based Med. 2017;17(8):869–75.
Zhan Y, He X, Hong D, Wang L, Li G. The current status of chronic kidney disease-mineral and bone disorder management in China. Sci Rep [Internet]. 2022;12(1):1–11. Available from: https://doi.org/10.1038/s41598-022-20790-8
Fernandez-Martin JL, Martinez-Camblor P, Dionisi MP, Floege J, Ketteler M, London G, et al. Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: The COSMOS study. Nephrol Dial Transplant. 2015;30(9):1542–51.
Fai Wan EY, Tak Yu EY, Chin WY, Fong DYT, Choi EPH, Tang EHM, et al. Burden of CKD and cardiovascular disease on life expectancy and health service utilization: A cohort study of hong kong Chinese hypertensive patients. J Am Soc Nephrol. 2019;30(10):1991–9.
Wang M, Obi Y, Streja E, Rhee CM, Lau WL, Chen J, et al. Association of parameters of mineral bone disorder with mortality in patients on hemodialysis according to level of residual kidney function. Clin J Am Soc Nephrol. 2017;12(7):1118–27.
Nurhan S, Kenan A, Gültekin S. Current Status of Renal Replacement Therapy in Turkey: A Summary of the 2019 Turkish Society of Nephrology Registry Report. Turkish J Nephrol [Internet]. 2021;30(2):105–11. Available from: https://turkjnephrol.org/en/current-status-of-renal-replacement-therapy-in-turkey-a-summary-of-the-2019-turkish-society-of-nephrology-registry-report-1628617
Nefroloji TD. Diyaliz Tedavisi Alan Hasta Sayısı. AA [Internet]. 2023; Available from: https://www.aa.com.tr/tr/saglik/turk-nefroloji-dernegi-bobrek-hastaliklarina-ve-yayginligina-dikkati-cekti/3163411#:~:text=Türkiye’de bu yıl itibarıyla,ev hemodiyalizi ile tedavi ediliyor
Vikrant S, Parashar A. Prevalence and severity of disordered mineral metabolism in patients with chronic kidney disease: A study from a tertiary care hospital in India. Indian J Endocrinol Metab [Internet]. 2016;20(4):460–7. Available from: https://pubmed.ncbi.nlm.nih.gov/27366711/
Leaf DE, Wolf M. A Physiologic–Based Approach to the Evaluation of a Patient With Hyperphosphatemia. Am J Kidney Dis [Internet]. 2013;61(2):330–6. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505500/
Evans M, Lewis RD, Morgan AR, Whyte MB, Hanif W, C Bain S, et al. A Narrative Review of Chronic Kidney Disease in Clinical Practice: Current Challenges and Future Perspectives. Adv Ther. 2022;39(1):33–43.
Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease. Kidney Int. 2007;71(1):31–8.
Moe SM. Renal Osteodystrophy or Kidney-Induced Osteoporosis? Curr Osteoporos Rep. 2017;15(3):194–7.
Kültür T, Çifci A, İnanır A. Kronik böbrek hastalığında kemik-mineral metabolizması bozuklukları (renal osteodistrofi) ve tedavi yaklaşımı. Ortadoğu Med J. 2016;8(4):214–2017.
Zheng C, Zheng J, Wu C, Lu C, Shyu J, Yung-Ho H, et al. Bone loss in chronic kidney disease: Quantity or quality? Bone. 2016;87:57–70.
Şit D. Kronik Böbrek Hastalıgındakemik korunması (mineral kemik hastalıkları) [Internet]. Available from: https://gunceltipdernegi.org/pdf/8/dede-sit-0411.pdf
KDIGO. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD). Off J Int Soc Y Nephrol [Internet]. 2017;7(1):3–56. Available from: https://kdigo.org/wp-content/uploads/2017/02/2017-KDIGO-CKD-MBD-GL-Update.pdf
Ersoy A, Gül CB. Geçmişten Geleceğe Epidemiyoloji [Internet]. 1. Baskı. İmamoğlu Ş, Ersoy CÖ, editors. Ankara: Miki Matbaacılık Ltd. Şti.; 2019. 365–380 p. Available from: https://file.temd.org.tr/Uploads/publications/books/documents/Gecmisten-Gelecege-Endokrinoloji.pdf
Lu KC, Ma WY, Yu JC, Wu CC, Chu P. Bone turnover markers predict changes in bone mineral density after parathyroidectomy in patients with renal hyperparathyroidism. Clin Endocrinol (Oxf). 2012;76(5):634–42.
Messa P, Macário F, Magdi Y, Koen B, Johann B, Beat von A, et al. The OPTIMA study: assessing a new cinacalcet (Sensipar/Mimpara) treatment algorithm for secondary hyperparathyroidism. Clin J Am Soc Nephrol. 2008;3(1):36–45.
Moorthi RN, Armstrong CLH, Janda K, Ponsler-Sipes K, Asplin JR, Moe SM. The effect of a diet containing 70% protein from plants on mineral metabolism and musculoskeletal health in chronic kidney disease. Am J Nephrol. 2014;40(6):582–91.
Waziri B, Duarte R, Naicker S. Chronic Kidney Disease - Mineral and Bone Disorder (CKD-MBD). Int J Nephrol Renovasc Dis. 2019;12:263–76.
Ferreira A, Frazão JM, Monier-Faugere M-C, Gil C, Galvao J, Oliveira C, et al. Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients. J Am Soc Nephrol [Internet]. 2008;19(2):405–12. Available from: https://pubmed.ncbi.nlm.nih.gov/18199805/
Vogiatzaki E, Michou V, Liakopoulos V, Roumeliotis A, Roumeliotis S, Kouidi E, et al. The effect of a 6-month intradialytic exercise program on hemodialysis adequacy and body composition: a randomized controlled trial. Int Urol Nephrol [Internet]. 2022;54(11):2983–93. Available from: https://doi.org/10.1007/s11255-022-03238-w
Rysz J, Franczyk B, Rokicki R, Gluba‐brzózka A. The influence of dietary interventions on chronic kidney disease–mineral and bone disorder (Ckd‐mbd). Nutrients. 2021;13(6):1–20.
Tsai W-C, Yang J-Y, Luan C-C, Wang Y-J, Lai Y-C, Liu L-C, et al. Additional benefit of dietitian involvement in dialysis staffs-led diet education on uncontrolled hyperphosphatemia in hemodialysis patients. Clin Exp Nefrol. 2016;20(5):812–21.
Hsu CC, Chen SR, Lee PH, Lin PC. The Effect of Music Listening on Pain, Heart Rate Variability, and Range of Motion in Older Adults After Total Knee Replacement. Clin Nurs Res [Internet]. 2019 Jun 1 [cited 2021 Jan 31];28(5):529–47. Available from: http://journals.sagepub.com/doi/10.1177/1054773817749108
Chen Z, Chen Xinxin NX, Zhang X, Yin S, Xiao G. Dietary knowledge-attitude-practice status in hemodialysis patients: a latent profile analysis. BMC Public Health. 2024;24(1):836.
Vardanjani RL, Parvin N, Mahmoodi SG. The effects of an individual, multistep intervention on adherence to treatment in hemodialysis patients. Disabil Rehabil. 2016;38(8):768–72.
Topbaş E. Diyaliz Hastalarının Beslenmesinde Davranış Değişikliği. Türk Nefroloji, Diyaliz ve Transplant Hemşireleri Derneği Nefroloji Hemşireliği Derg [Internet]. 2017;1(12):29–35. Available from: https://dergipark.org.tr/tr/download/article-file/360013
Joshi S, Potluri V, Shah S. Dietary Management of Hyperphosphatemia. Am J Kidney Dis. 2018;72(1):155–6.
Caldeira D, Amaral T, David C, Sampaio C. Educational Strategies to Reduce Serum Phosphorus in Hyperphosphatemic Patients With Chronic Kidney Disease: Systematic Review With Meta-analysis. J Ren Nutr. 2011;21(4):285–94.
Ghimire S, Lee K, Jose MD, Castelino RL, Zaidi STR. Adherence assessment practices in haemodialysis settings: A qualitative exploration of nurses and pharmacists’ perspectives. J Clin Nurs. 2019;28(11–12):2197–205.
Van Zuilen AD, Bots ML, Dulger A, Van Der Tweel I, Van Buren M, Ten Dam MAGJ, et al. Multifactorial intervention with nurse practitioners does not change cardiovascular outcomes in patients with chronic kidney disease. Kidney Int [Internet]. 2012;82(6):710–7. Available from: http://dx.doi.org/10.1038/ki.2012.137
Mayne TJ, Benner D, Ricketts K, Burgess M, Wilson S, Poole L, et al. Results of a Pilot Program to Improve Phosphorus Outcomes in Hemodialysis Patients. J Ren Nutr. 2012;22(5):472–9.
Ok E, Kutlu Y. The Effect of Motivational Interviewing on Adherence to Treatment and Quality of Life in Chronic Hemodialysis Patients: A Randomized Controlled Trial. Clin Nurs Res. 2021;30(3):322–33.
Yangöz ŞT, Özer Z. Hemodiyaliz Tedavisi Uygulanan Bireylerde Sıvı Alımına, Diyet ve İlaç Yönetimine Uyumda Motivasyonel Görüşmenin Etkisi: Sistematik Derleme. Turkiye Klin J Nurs Sci. 2020;12(3):419–29.
Park Y, Kim S. Health Literacy-Based Self-Management Intervention for Patient-Family Caregiver Dyads Undergoing Hemodialysis. Rehabil Nurs. 2022;47(5):187–97.
Kim H, Jeong I, Cho M. Effect of Treatment Adherence Improvement Program in Hemodialysis Patients: A Systematic Review and Meta-Analysis. Int J Env Res Public Heal. 2022;19(18):2–25.
Park OL, Kim SR. Integrated self-management program effects on hemodialysis patients: A quasi-experimental study. Jpn J Nurs Sci. 2019;16(4):396–409.
Alikari V, Tsironi M, Matziou V, Foteini T, Stathoulis, John Babatsikou F. The impact of education on knowledge, adherence and quality of life among patients on haemodialysis. Qual Life Res. 2019;28(1):73–83.
Griva K, Nandakumar M, H Ng J-A, Lam KFY, McBain H, Newman SP. Hemodialysis Self-management Intervention Randomized Trial (HED-SMART): A Practical Low-Intensity Intervention to Improve Adherence and Clinical Markers in Patients Receiving Hemodialysis. Am J Kidney Dis. 2018;71(3):371–81.
Kauric-Klein Z, Peters RM, Yarandi HN. Self-Efficacy and Blood Pressure Self-Care Behaviors in Patients on Chronic Hemodialysis. West J Nurs Res. 2017;39(7):887–905.
Yun KS, Choi JY. Effects of Dietary Program based on Self-efficacy Theory on Dietary Adherence, Physical Indices and Quality of Life for Hemodialysis Patients. J Korean Acad Nurs. 2016;46(4):598–609.
Kim CE. Effects of Individualized Diet Education Program on the Dietary Knowledge and Self-Care Compliance among Hemodialysis Patients. J Korean Clin Nurs Res.2016;22(3): 25.
